hypothes
case
growth
data
reveal
efficaci
npi
studi
conduct
secondari
analysi
case
growth
data
compar
differ
effect
npi
among
repres
countri
world
studi
leverag
publicli
avail
data
learn
pattern
dynam
chang
reproduct
rate
sixteen
countri
cover
asia
europ
north
america
south
america
australia
africa
furthermor
model
relationship
cumul
number
case
dynam
reproduct
rate
character
effect
npi
learn
four
level
npi
accord
effect
control
growth
categor
countri
correspond
group
dynam
chang
reproduct
rate
learn
via
linear
regress
model
studi
countri
averag
adjust
rsquar
confid
interv
china
south
korea
argentina
australia
first
level
npi
effect
japan
egypt
second
level
sever
acut
respiratori
syndrom
coronaviru
coronaviru
diseas
spread
rapidli
global
pandem
declar
march
affect
countri
contin
current
outbreak
rais
great
concern
worldwid
unit
state
america
us
countri
eg
itali
spain
franc
germani
netherland
unit
kingdom
uk
europ
epicent
pandem
brief
document
produc
public
health
england
govern
state
outbreak
expect
last
around
one
year
spring
around
popul
infect
peopl
million
requir
hospit
uk
mani
countri
implement
flight
restrict
other
impos
lockdown
close
border
mitig
exponenti
spread
within
countri
mani
nonpharmaceut
intervent
npi
reduc
spread
rate
implement
includ
social
distanc
case
isol
home
quarantin
school
univers
close
et
ac
recogn
npi
reduc
reproduct
rate
thu
chang
growth
trend
sinc
variou
type
npi
mani
factor
may
impact
challeng
measur
impact
npi
control
growth
directli
assum
timeseri
cumul
number
case
reflect
effect
npi
therefor
propos
develop
informat
strategi
conduct
secondari
timeseri
data
analysi
learn
grow
pattern
character
efficaci
npi
aim
model
dynam
chang
reproduct
rate
time
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
leverag
demonstr
extent
npi
impact
growth
upon
relationship
cumul
number
case
dynam
chang
reproduct
rate
compar
differ
effect
npi
across
sixteen
countri
cover
asia
europ
north
america
south
america
australia
africa
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
april
collect
record
repres
number
cumul
case
countri
specif
day
instanc
us
case
april
prepar
studi
compos
cohort
defin
observ
observ
record
made
countri
date
cumul
number
confirm
case
mention
sinc
start
date
pandem
countri
differ
use
time
th
case
confirm
rel
start
date
align
growth
countri
sinc
countri
differ
popul
eg
spain
china
normal
cumul
number
case
number
case
per
million
peopl
introduc
three
notat
number
day
date
th
case
confirm
ii
ncase
observ
cumul
number
case
per
million
day
iii
b
observ
cumul
number
case
per
million
day
th
case
confirm
use
defin
three
notat
model
rd
defin
overal
reproduct
rate
past
day
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
assum
ncase
give
none
npi
adopt
without
npi
follow
natur
spread
satisfi
reproduct
rate
day
instanc
infect
peopl
day
person
affect
person
averag
next
day
person
infect
day
total
number
infect
peopl
day
day
assum
rd
fix
dynam
chang
day
npi
adopt
appropri
countri
use
rd
calcul
overal
reproduct
rate
past
day
rd
continu
npi
assum
rd
decreas
linearli
day
propos
leverag
linear
regress
model
learn
relationship
variabl
rd
rd
upon
regress
model
predict
rd
ncase
day
call
estim
valu
refer
r
ncase
respect
learn
relationship
dynam
chang
reproduct
rate
cumul
number
case
repres
cumul
number
case
per
million
popul
specif
day
given
overal
reproduct
rate
past
day
rd
valu
rd
decreas
day
point
higher
rd
point
demonstr
effect
npi
lower
reproduct
rate
mani
day
requir
reach
cumul
number
case
instanc
requir
day
reach
case
per
million
popul
reproduct
rate
rd
day
reach
number
case
reproduct
rate
leverag
effect
npi
requir
mani
day
reach
target
cumul
number
case
time
avoid
arriv
peak
eg
shown
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
reach
target
number
blue
line
avoid
reach
higher
peak
case
per
million
day
shown
figur
hypothes
effect
npi
character
height
peak
defin
point
made
day
cumul
number
case
ncase
day
smaller
valu
ncase
peak
effect
npi
accord
cumul
number
case
peak
number
day
reach
peak
develop
four
level
npi
four
level
npi
lower
cumul
number
case
smaller
number
day
ii
lower
cumul
number
case
bigger
number
day
iii
higher
cumul
number
case
smaller
number
day
iv
higher
cumul
number
day
bigger
number
day
countri
first
level
effect
npi
lower
cumul
number
case
shorter
time
arriv
peak
countri
fourth
level
ineffect
npi
higher
cumul
number
case
longer
time
arriv
peak
sinc
countri
yet
arriv
peak
use
estim
r
calcul
cumul
number
case
ncase
peak
number
day
need
reach
peak
accord
r
r
decreas
specif
valu
rpeak
valu
decreas
set
day
dpeak
reach
maximum
number
turn
point
shown
figur
use
dpeak
estim
cumul
number
case
countri
day
npeak
rpeak
peak
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
rd
decreas
day
point
target
number
case
number
day
arriv
target
number
differ
vs
use
effect
nonpharmaceut
intervent
make
rd
smaller
requir
mani
day
reach
target
number
benefit
growth
trend
avoid
arriv
higher
peak
shown
figur
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
dynam
chang
reproduct
rate
figur
show
decreas
trend
observ
rd
countri
mention
method
section
rd
leverag
character
overal
reproduct
rate
past
day
sinc
rd
dynam
first
sever
day
use
data
rd
start
day
model
decreas
trend
shown
bottom
figur
coeffici
intercept
adjust
rsquar
pvalu
shown
tabl
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
figur
smaller
observ
predict
number
case
countri
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
grow
trend
eight
countri
observ
cumul
number
case
larger
per
million
popul
top
correspond
estim
number
case
condit
day
reproduct
rate
rd
xaxi
number
day
sinc
case
confirm
yaxi
cumul
number
observ
top
estim
bottom
case
per
million
popul
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
effect
npi
thu
overal
reproduct
rate
lowest
number
day
reach
peak
smallest
second
class
includ
egypt
japan
two
countri
cumul
number
case
low
peak
requir
long
time
arriv
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
peak
shown
bottom
figur
third
group
includ
countri
europ
germani
itali
netherland
spain
franc
higher
cumul
number
case
peak
requir
rel
short
time
reach
peak
fourth
class
includ
us
uk
highest
cumul
number
fo
case
peak
requir
longest
time
reach
peak
demonstr
two
countri
ineffici
npi
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
challeng
quantifi
effect
npi
eg
social
distanc
household
quarantin
spread
trend
direct
way
paper
use
indirect
way
model
growth
trend
reveal
differ
effect
npi
among
repres
countri
leverag
dynam
chang
pattern
reproduct
rate
demonstr
effect
npi
categor
investig
countri
four
group
accord
effect
adopt
npi
china
south
korea
effect
npi
first
group
shown
epidem
long
way
japan
egypt
shown
figur
still
requir
longer
time
arriv
peak
fortun
estim
cumul
number
case
peak
rel
small
effect
npi
two
countri
rank
second
strategi
increas
time
reach
peak
avoid
higher
one
countri
europ
third
class
effect
npi
media
number
infect
peopl
per
million
popul
big
european
countri
except
uk
investig
european
countri
almost
arriv
peak
us
uk
special
fourth
class
ineffici
npi
highest
cumul
number
case
time
requir
longest
time
arriv
peak
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
growth
trend
india
hard
model
accord
exist
data
sever
potenti
reason
one
could
report
number
inaccur
could
repres
actual
pandem
india
sever
limit
studi
wish
highlight
guid
futur
research
area
first
dynam
chang
reproduct
rate
may
impact
mani
reason
npi
countri
factor
influenc
growth
approach
measur
effect
npi
limit
second
use
estim
peak
categor
effect
npi
four
differ
level
although
estim
cumul
number
case
consist
observ
part
high
adjust
rsquar
potenti
deriv
observ
one
futur
spread
third
studi
aim
quantifi
overal
effect
npi
case
grow
trend
consid
impact
npi
school
univers
close
grow
trend
due
limit
data
inform
lack
approach
separ
npi
consid
whole
studi
fourth
pattern
grow
learn
report
case
number
may
underestim
given
shortag
unavail
test
kit
mani
countri
find
learn
data
may
bias
avail
number
test
kit
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
appli
timeseri
case
growth
data
learn
dynam
chang
reproduct
rate
leverag
reproduct
rate
tool
compar
effect
npi
among
countri
world
compar
effect
npi
countri
china
south
korea
australia
argentina
effect
npi
us
uk
ineffect
npi
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
author
compet
interest
declar
yc
yf
cy
xz
cg
perform
data
collect
analysi
method
design
experi
design
evalu
interpret
experi
write
manuscript
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
